|
“Evolving
Role of Tandem Mass Spectrometry in Contemporary Protein Science”
Neil
L. Kelleher, Ph.D. Associate Professor of Chemistry, University of
Illinois Urbana, IL. (bio)

ABSTRACT
Fragmentation
of gas phase ions allows a type of fingerprinting that has been used
for years in mass spectrometry to identify and characterize molecules
in complex mixtures. Over the decades, the mass of ions that amenable
to direct fragmentation for tandem mass spectrometry has been
increasing steadily. From small molecules to small peptides to small
proteins and intact protein complexes now are analyzed by high
resolution tandem mass spectrometry. This historical progression of
technology now allows a "top down" philosophy of molecular
analysis to be implemented for intact proteins to capture any mass
shift occurring on protein molecules, such as coding polymorphisms,
alternative splicing, and post-translational modifications. Recent
progress along this general line of investigation will be reviewed for
non-mass spectrometrists, with illustrations of an integrated approach
incorporating protein separations, new mass spectrometers, and novel
database curation/search strategies to allow initial implementation of
Top Down Proteomics for yeast and human cells.
Summary
(by Barnett Institute Staff)
The
size limit of mass spectrometry has been steadily increasing since its
inception in 1901: from ions, to molecules, to proteins of 10-30 kDa. We should anticipate 100 kDa. In addition to
getting the molecules "to fly", the high resolution of FTMS
is needed to resolve isotopic envelopes.
The
top-down approach is used for comprehensive characterization of a
protein, in contrast to proteomic profiling, which tabulates as many
proteins as possible present in a sample . Analysis
of intact proteins, or large fragments, can distinguish
"when some are glycosylated and some are acetylated, from when
some are glycosylated and acetylated", i.e. when modifications
are correlated. In the bottom- up proteomic approach proteins are
cleaved into fragments, typically less than
5 kDa. But why throw out the stellar technical achievement we have worked so hard for,
of being
able to analyze larger fragments -- especially if the most important biological information is in
it? Bottom-up typically gives only 5-50% sequence coverage -- it
indicates a gene is expressed, but cannot reliably
discern which isoform of the gene is expressed or post-translational
modifications are made -- a stated goal of proteomics.
The
value of top down is illustrated in an analysis of histones.
There are 30 million nucleosomes in the genome; all are the
same 4 histone proteins, but the histones have tails that hang out and
can be modified to signal whether the DNA inside should be expressed
or is silenced. Deciphering and reading this histone code is
crucial to understanding gene expression. Methylation at lysine 4 is
thought to be a signal; several sites of acetylation also
occur. It was an open question whether the
methylation and acylation are cause-and-effect; some say these
modifications are mutually exclusive. But the MS data shows
acetylation correlates with, is not antagonistic to, methylation.
All
of the histone modification states seen
with top-down have been tabulated. 170 modification states -- specific
combinations of modifications -- have been
characterized and catalogued, which has enabled shotgun
proteomics of histone modifications. Also, noting that only 10% of the
peptides in bottom-up proteomic analysis are identifiable, Dr.
Kelleher has added the posttranslational modifications to a database
search algorithm. ProSight PTM is available on the web.
He
has also contributed a top-down analog of Yates' mudPIT. In mudCAT (multi-dimensional
characterized by top-down), intact proteins are separated over
tandem chromatographic columns, with anion exchange steps eluted
directly onto sequential RPLC separations. Once characterized, a
protein can be identified quickly in subsequent samples from its exact
mass, without repeating the detailed MS/MS analysis and database
search.

Wolfgang
Goetzinger (Amgen); Ian Parsons (Momenta); Tomas Rejtar (Barnett
Institute).
Neil
L. Kelleher, Ph.D. - Professor Kelleher received a B.S. and B.A.
from Pacific Lutheran University in 1992, a Fulbright Fellowship the
following year, and a Ph.D. from Cornell University in 1997. After a
NIH Postdoctoral Fellowship at Harvard Medical School with Chris
Walsh, Kelleher joined the faculty at University of Illinois at
Urbana- Champaign in 1999 as a bioanalytical chemist. Kelleher has
interest in Mass Spectrometry-based enzymology of natural product
biosynthesis and development of Fourier Transform Mass Spectrometry (FTMS)
for “Top Down” proteomics using intact proteins (no proteases) for
efficient detection of their post-translational modifications (such as
those found in chromatin).
Kelleher
has received several awards including a Packard Fellowship, an Alfred
P. Sloane Fellowship, a Presidential Early Career Award, the National
Science Foundation CAREER Award, the Lilly Analytical Chemistry Award,
and support from the Burroughs Wellcome, the Searle, and the Dreyfus
Foundations.
|